Return On Equity of INTEGRATED BIOPHARMA INC from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
INTEGRATED BIOPHARMA INC quarterly and annual Return On Equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • INTEGRATED BIOPHARMA INC Return On Equity for the quarter ending 30 Sep 2025 was 3%, a 47% increase year-over-year.
  • INTEGRATED BIOPHARMA INC annual Return On Equity for 2025 was 4%, a 582% increase from 2024.
  • INTEGRATED BIOPHARMA INC annual Return On Equity for 2024 was 1%.
  • INTEGRATED BIOPHARMA INC annual Return On Equity for 2023 was 0%, a 101% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

INTEGRATED BIOPHARMA INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 3% +1% +47% 01 Jul 2025 30 Sep 2025
Q2 2025 4% +3% +582% 01 Apr 2025 30 Jun 2025
Q1 2025 6% +7% 01 Jan 2025 31 Mar 2025
Q4 2024 5% +8% 01 Oct 2024 31 Dec 2024
Q3 2024 2% +3% 01 Jul 2024 30 Sep 2024
Q2 2024 1% +1% 01 Apr 2024 30 Jun 2024
Q1 2024 -1% -11% -106% 01 Jan 2024 31 Mar 2024
Q4 2023 -3% -15% -123% 01 Oct 2023 31 Dec 2023
Q3 2023 0% -19% -102% 01 Jul 2023 30 Sep 2023
Q2 2023 0% -23% -101% 01 Apr 2023 30 Jun 2023
Q1 2023 10% -34% -77% 01 Jan 2023 31 Mar 2023
Q4 2022 12% -41% -77% 01 Oct 2022 31 Dec 2022
Q3 2022 19% -44% -70% 01 Jul 2022 30 Sep 2022
Q2 2022 23% -58% -71% 01 Apr 2022 30 Jun 2022
Q1 2022 44% -25% -36% 01 Jan 2022 31 Mar 2022
Q4 2021 53% -26% -33% 01 Oct 2021 31 Dec 2021
Q3 2021 63% -31% -33% 01 Jul 2021 30 Sep 2021
Q2 2021 81% -24% -23% 01 Apr 2021 30 Jun 2021
Q1 2021 69% -21% -23% 01 Jan 2021 31 Mar 2021
Q4 2020 79% -38% -33% 01 Oct 2020 31 Dec 2020
Q3 2020 94% -29% -24% 01 Jul 2020 30 Sep 2020
Q2 2020 105% -66% -39% 01 Apr 2020 30 Jun 2020
Q1 2020 90% +359% 01 Jan 2020 31 Mar 2020
Q4 2019 117% +178% 01 Oct 2019 31 Dec 2019
Q3 2019 123% +147% 01 Jul 2019 30 Sep 2019
Q2 2019 171% +183% 01 Apr 2019 30 Jun 2019
Q1 2019 -270% 01 Jan 2019 31 Mar 2019
Q4 2018 -61% 01 Oct 2018 31 Dec 2018
Q3 2018 -23% 01 Jul 2018 30 Sep 2018
Q2 2018 -11% 01 Apr 2018 30 Jun 2018
Q1 2016 -1% +6% +85% 01 Jan 2016 31 Mar 2016
Q4 2015 0% +4% 01 Oct 2015 31 Dec 2015
Q3 2015 -6% -4% -160% 01 Jul 2015 30 Sep 2015
Q2 2015 -8% -7% -494% 01 Apr 2015 30 Jun 2015
Q1 2015 -8% +3% +26% 01 Jan 2015 31 Mar 2015
Q4 2014 -4% +5% +57% 01 Oct 2014 31 Dec 2014
Q3 2014 -2% +11% +82% 01 Jul 2014 30 Sep 2014
Q2 2014 -1% 0% -53% 01 Apr 2014 30 Jun 2014
Q1 2014 -10% -31% -150% 01 Jan 2014 31 Mar 2014
Q4 2013 -9% -33% -139% 01 Oct 2013 31 Dec 2013
Q3 2013 -13% -55% -131% 01 Jul 2013 30 Sep 2013
Q2 2013 -1% -32% -103% 01 Apr 2013 30 Jun 2013
Q1 2013 21% -6% -23% 01 Jan 2013 31 Mar 2013
Q4 2012 24% 01 Oct 2012 31 Dec 2012
Q3 2012 42% 01 Jul 2012 30 Sep 2012
Q2 2012 31% 01 Apr 2012 30 Jun 2012
Q1 2012 27% 01 Jan 2012 31 Mar 2012

INTEGRATED BIOPHARMA INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 4% +3% +582% 01 Jul 2024 30 Jun 2025
2024 1% +1% 01 Jul 2023 30 Jun 2024
2023 0% -23% -101% 01 Jul 2022 30 Jun 2023
2022 23% -58% -71% 01 Jul 2021 30 Jun 2022
2021 81% -24% -23% 01 Jul 2020 30 Jun 2021
2020 105% -66% -39% 01 Jul 2019 30 Jun 2020
2019 171% +183% 01 Jul 2018 30 Jun 2019
2018 -11% -13% -739% 01 Jul 2017 30 Jun 2018
2017 2% +11% 01 Apr 2017 31 Mar 2018
2016 -9% -1% -13% 01 Apr 2016 31 Mar 2017
2015 -8% -7% -494% 01 Jul 2014 30 Jun 2015
2014 -1% 0% -53% 01 Jul 2013 30 Jun 2014
2013 -1% -32% -103% 01 Jul 2012 30 Jun 2013
2012 31% 01 Jul 2011 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.